Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000139 | Golgi membrane | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 12 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 5 | 2 |
GO:0012506 | vesicle membrane | 4 | 2 |
GO:0012507 | ER to Golgi transport vesicle membrane | 6 | 2 |
GO:0016020 | membrane | 2 | 12 |
GO:0030658 | transport vesicle membrane | 5 | 2 |
GO:0030659 | cytoplasmic vesicle membrane | 5 | 2 |
GO:0030662 | coated vesicle membrane | 5 | 2 |
GO:0031090 | organelle membrane | 3 | 12 |
GO:0031201 | SNARE complex | 3 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0098588 | bounding membrane of organelle | 4 | 2 |
GO:0098796 | membrane protein complex | 2 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: Q4QDI1
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 12 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 4 | 12 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 6 | 12 |
GO:0006906 | vesicle fusion | 6 | 2 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0007030 | Golgi organization | 5 | 2 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0016050 | vesicle organization | 5 | 2 |
GO:0016192 | vesicle-mediated transport | 4 | 12 |
GO:0046907 | intracellular transport | 3 | 12 |
GO:0048193 | Golgi vesicle transport | 5 | 12 |
GO:0048280 | vesicle fusion with Golgi apparatus | 6 | 2 |
GO:0048284 | organelle fusion | 5 | 2 |
GO:0051179 | localization | 1 | 12 |
GO:0051234 | establishment of localization | 2 | 12 |
GO:0051641 | cellular localization | 2 | 12 |
GO:0051649 | establishment of localization in cell | 3 | 12 |
GO:0061024 | membrane organization | 4 | 2 |
GO:0061025 | membrane fusion | 5 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0090174 | organelle membrane fusion | 6 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005484 | SNAP receptor activity | 3 | 12 |
GO:0030674 | protein-macromolecule adaptor activity | 2 | 12 |
GO:0060090 | molecular adaptor activity | 1 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 67 | 71 | PF00656 | 0.601 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.404 |
CLV_NRD_NRD_1 | 193 | 195 | PF00675 | 0.442 |
CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.264 |
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 256 | 260 | PF00082 | 0.341 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.339 |
DEG_APCC_DBOX_1 | 214 | 222 | PF00400 | 0.488 |
DOC_CKS1_1 | 121 | 126 | PF01111 | 0.629 |
DOC_CYCLIN_RxL_1 | 88 | 97 | PF00134 | 0.527 |
DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.744 |
DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.506 |
DOC_USP7_MATH_1 | 58 | 62 | PF00917 | 0.607 |
DOC_WW_Pin1_4 | 120 | 125 | PF00397 | 0.627 |
DOC_WW_Pin1_4 | 45 | 50 | PF00397 | 0.591 |
LIG_14-3-3_CanoR_1 | 256 | 262 | PF00244 | 0.365 |
LIG_Actin_WH2_2 | 79 | 97 | PF00022 | 0.514 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.579 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.761 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.565 |
LIG_FHA_2 | 121 | 127 | PF00498 | 0.573 |
LIG_FHA_2 | 155 | 161 | PF00498 | 0.709 |
LIG_FHA_2 | 221 | 227 | PF00498 | 0.464 |
LIG_LIR_Apic_2 | 260 | 264 | PF02991 | 0.390 |
LIG_LIR_Gen_1 | 112 | 122 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 61 | 70 | PF02991 | 0.541 |
LIG_LIR_LC3C_4 | 82 | 87 | PF02991 | 0.567 |
LIG_LIR_Nem_3 | 112 | 118 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 61 | 66 | PF02991 | 0.527 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.414 |
LIG_MAD2 | 41 | 49 | PF02301 | 0.557 |
LIG_PDZ_Class_2 | 275 | 280 | PF00595 | 0.305 |
LIG_Pex14_2 | 270 | 274 | PF04695 | 0.398 |
LIG_Pex14_2 | 275 | 279 | PF04695 | 0.380 |
LIG_PTB_Apo_2 | 194 | 201 | PF02174 | 0.638 |
LIG_PTB_Phospho_1 | 194 | 200 | PF10480 | 0.640 |
LIG_SH2_CRK | 135 | 139 | PF00017 | 0.589 |
LIG_SH2_CRK | 200 | 204 | PF00017 | 0.453 |
LIG_SH2_CRK | 261 | 265 | PF00017 | 0.305 |
LIG_SH2_GRB2like | 29 | 32 | PF00017 | 0.559 |
LIG_SH2_NCK_1 | 122 | 126 | PF00017 | 0.649 |
LIG_SH2_NCK_1 | 29 | 33 | PF00017 | 0.617 |
LIG_SH2_STAP1 | 234 | 238 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 122 | 125 | PF00017 | 0.568 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.529 |
LIG_SH2_STAT5 | 276 | 279 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.490 |
LIG_SUMO_SIM_anti_2 | 81 | 87 | PF11976 | 0.486 |
LIG_WRC_WIRS_1 | 63 | 68 | PF05994 | 0.497 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.756 |
MOD_CK2_1 | 120 | 126 | PF00069 | 0.554 |
MOD_CK2_1 | 220 | 226 | PF00069 | 0.464 |
MOD_CK2_1 | 58 | 64 | PF00069 | 0.628 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.492 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.494 |
MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.460 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.246 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.371 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.750 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.582 |
MOD_N-GLC_1 | 232 | 237 | PF02516 | 0.339 |
MOD_N-GLC_1 | 27 | 32 | PF02516 | 0.425 |
MOD_N-GLC_2 | 4 | 6 | PF02516 | 0.378 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.532 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.426 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.656 |
MOD_PKA_2 | 94 | 100 | PF00069 | 0.552 |
MOD_Plk_1 | 140 | 146 | PF00069 | 0.523 |
MOD_Plk_1 | 81 | 87 | PF00069 | 0.510 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.575 |
MOD_Plk_4 | 81 | 87 | PF00069 | 0.497 |
MOD_ProDKin_1 | 120 | 126 | PF00069 | 0.628 |
MOD_ProDKin_1 | 45 | 51 | PF00069 | 0.598 |
TRG_DiLeu_BaLyEn_6 | 253 | 258 | PF01217 | 0.464 |
TRG_ENDOCYTIC_2 | 135 | 138 | PF00928 | 0.581 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.452 |
TRG_ENDOCYTIC_2 | 276 | 279 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 63 | 66 | PF00928 | 0.488 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.434 |
TRG_ER_diArg_1 | 192 | 194 | PF00400 | 0.738 |
TRG_ER_diArg_1 | 254 | 257 | PF00400 | 0.453 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I327 | Leptomonas seymouri | 85% | 100% |
A0A0S4ITE2 | Bodo saltans | 51% | 100% |
A0A1X0P6D4 | Trypanosomatidae | 66% | 100% |
A0A3S7WVE2 | Leishmania donovani | 100% | 100% |
A0A422P3A7 | Trypanosoma rangeli | 67% | 100% |
A4H9Z8 | Leishmania braziliensis | 94% | 100% |
A4HY62 | Leishmania infantum | 100% | 100% |
D0A0I1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 100% |
E9ARZ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |
P22214 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 25% | 100% |
Q6C880 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 25% | 100% |
Q6CJA0 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 23% | 100% |
Q6FWT0 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 24% | 100% |
Q74ZD2 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 25% | 100% |
V5BBV8 | Trypanosoma cruzi | 68% | 100% |